2026-01-27 - Analysis Report
**Company Overview**
Morgan Stanley is a multinational investment bank and financial services company.

**Return Rate Comparison**
* Cumulative return of review stock (MS): 282.16%
* Cumulative return of comparison stock (VOO): 127.58%
* Divergence: 154.58% (max: 174.40, min: -20.30, current: 149.70, relative divergence: 87.30%)

The review stock's cumulative return is significantly higher than the comparison stock. The degree of divergence is substantial.

**Alpha, Beta Analysis**
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 6.0% | 21.5% | -2.0% | 1.6 | 63.0B |
| 2017-2019  | -14.0% | 21.5% | -39.0% | 1.3 | 81.2B |
| 2018-2020  | 14.0% | 49.7% | -10.0% | 1.4 | 108.9B |
| 2019-2021  | 123.0% | 49.7% | 59.0% | 1.4 | 156.0B |
| 2020-2022  | 55.0% | 49.7% | 51.0% | 1.3 | 135.1B |
| 2021-2023  | 32.0% | 30.4% | 14.0% | 1.1 | 148.2B |
| 2022-2024  | 27.0% | 30.4% | -3.0% | 1.1 | 199.8B |
| 2023-2025  | 148.0% | 28.7% | 73.0% | 1.3 | 282.1B |

The review stock's CAGR has varied over the years, with significant growth in some periods and significant declines in others.

**Recent Stock Price Fluctuations**
* Close: $181.88
* Last-market: {'price': 181.88, 'previousClose': 179.0, 'change': 1.61}
* 5-day SMA: $181.87
* 20-day SMA: $183.51
* 60-day SMA: $174.23

The review stock's price has shown moderate fluctuations, with a slight increase over the past 5 days.

**RSI, PPO Index Indicators and Other Metrics**
* Market Risk Indicator (MRI): 0.70 (0.9~1.0: High Investment Recommended, 0.7~0.9: Medium Investment, 0.4~0.7: Low Investment, <0.4: Very Risky)
* RSI: 44.17
* PPO: -0.57
* Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change: -12.70 (-): worsening
* 7-day Rank change: -5 (-): rank down
* 7-day Dynamic Expected Return change: 9.10 (+): improving

The review stock's RSI and PPO indicators suggest potential buying opportunities.

**Expected Return and Excess Return**
* Expected Return (%): 13.40%
* Expected excess return compared to S&P 500 if invested long-term (more than 2 years) from this point.

**Recent News & Significant Events**
The review stock has been influenced by various news and events, including:

* [2026-01-26] Microsoft Stock Before Q2 Earnings: Buy Now or Wait for Results? - Zacks Investment Research (news.google.com)
* [2026-01-26] Why JPM, BAC, and MS Stocks Are Buoyant in Banking’s ‘Next Phase’ - TipRanks (news.google.com)
* [2026-01-26] Microsoft’s Maia 200 AI chip launch leaves Nvidia stock little changed - Investing.com (news.google.com)
* [2026-01-23] Microsoft (MSFT) Stock Is Up, What You Need To Know - Yahoo Finance (news.google.com)
* [2026-01-26] Morgan Stanley $MS Shares Sold by Mutual of America Capital Management LLC - MarketBeat (news.google.com)
* [2026-01-25] Should You Buy Microsoft Stock Before Earnings? - The Motley Fool (news.google.com)

**Analyst Opinions**
Analyst Consensus:
* Key: Buy
* Mean (1=StrongBuy~5=Sell): 2.40 (~Buy)
* Opinions: 21
* Target Price (avg/high/low): 193.00 / 221.00 / 148.00

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-29 | 3.73 | 77.67 B$ |
| 2025-04-30 | 3.47 | 70.07 B$ |
| 2025-01-29 | 3.24 | 69.63 B$ |
| 2024-10-30 | 3.32 | 65.58 B$ |
| 2025-10-29 | 3.32 | 65.58 B$ |

The review stock's EPS and revenue have shown moderate fluctuations over the past quarters.

**Financial Information**
Since no 'Total Revenue' or 'Gross Profit' data is available for MS, we cannot display a table or provide an analysis of the provided quarterly data.

**Comprehensive Analysis**
The review stock has shown significant growth and volatility over the years. The RSI and PPO indicators suggest potential buying opportunities, while the MRI suggests a medium risk level. The analyst consensus is positive, with a mean rating of 2.40 and a target price of $193.00. The review stock's EPS and revenue have shown moderate fluctuations over the past quarters.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.